Effects of probenecid on the pharmacokinetics of allopurinol riboside.
AUTOR(ES)
Were, J B
RESUMO
Allopurinol riboside is an experimental agent for the treatment of leishmaniasis and American trypanosomiasis. Previous studies showed that after oral administration, unexpectedly low levels of allopurinol riboside in plasma are attributable to incomplete absorption and rapid renal clearance. In this randomized, crossover evaluation in healthy volunteers, probenecid reduces the renal clearance of allopurinol riboside, extends the half-life of allopurinol riboside in plasma, and triples the levels of allopurinol riboside in plasma.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=187932Documentos Relacionados
- Effects of probenecid on the pharmacokinetics and elimination of acyclovir in humans.
- Effect of probenecid on the pharmacokinetics of cefmenoxime.
- Effect of probenecid on the pharmacokinetics of moxalactam.
- Pharmacokinetics of intravenously administered cefmetazole and cefoxitin and effects of probenecid on cefmetazole elimination.
- Effect of orally administered probenecid on the pharmacokinetics of cefoxitin.
